Outsourcing

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Articles

CMOs may be gaining as strategic partners to large bio/pharma companies, but they have a much harder path to navigate.

CMOs and CROs Have Different Trajectories

Vicky Qing XIA is Project Director at BioPlan Associates.

New study shows China biopharma companies face staffing shortages.

Staffing for China’s Rapidly Growing Biomanufacturing Industry

Moving global manufacturing operations may be more complicated than it appears.

Will Pharma Manufacturing Move Back to the US?

Gil Roth is president of the Pharma & Biopharma OutsourcingAssociation, gil.roth@pharma-bio.org.

The outlook for the CMO and CDMO industry may be affected by ever-changing politics.

Viewpoint: Challenges and Opportunities for CDMOs

Robust venture capital investment gives CDMOs and CROs a positive outlook for 2017.

The Tide Stays High

M&A activity, new business models, fundraising limits, offerings from small CDMOs, and combination products are driving decisions in the contract services market..

Internal and External Factors to Shape CMO Industry

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Biosimilars may be the key to CMO growth.

Biosimilars Supporting Contract Manufacturers’ Growth

CMO executives are focusing on M&A activity, new business models, and fundraising limits.

Five Themes That Will Drive the CMO Industry

This key bioprocessing segment is expecting continued growth

Fill/Finish Outsourcing

The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.

Outsourcing Outlook